As an isoenzyme of SRD5A1 and SRD5A2, SRD5A3 has been discovered lately and it is demonstrated as an oncogene and confers a poor prognosis in several human cancers, such as breast cancer [25] and hepatocellular carcinoma [26]. The gene discussed is SRD5A2; the disease is cancer.